GeneDx amends Executive Chairman agreement: reduced time, base salary $337,500

GeneDx Holdings Corp.

Jason Ryan's employment as Executive Chairman extended to Dec 31, 2023.
For 2023, Ryan will work 50% time with base salary of $337,500.
Target annual performance bonus for 2023 set at 100% of base salary.
Amendment effective April 10, 2023; prior vesting End Date unchanged as Dec 31, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.